[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100420993":3},{"organization":4,"armGroups":7,"interventions":8,"overallOfficials":7,"centralContacts":13,"locations":22,"responsibleParty":40,"collaborators":42,"id":53,"slug":54,"hasResults":55,"nctId":56,"briefTitle":57,"officialTitle":58,"acronym":59,"eligibilityCriteria":60,"healthyVolunteers":55,"sex":61,"minAge":62,"maxAge":7,"enrollmentInfo":63,"targetDuration":7,"studyType":66,"phases":7,"briefSummary":67,"conditions":68,"keywords":70,"overallStatus":25,"whyStopped":7,"lastUpdateSubmitDate":74,"lastUpdatePostDateStruct":75,"startDateStruct":78,"completionDateStruct":80,"leadSponsor":82,"locationsCount":83},{"fullName":5,"class":6},"University of Leicester","OTHER",null,[9],{"type":10,"name":11,"description":12,"armGroupLabels":7,"otherNames":7},"DIAGNOSTIC_TEST","CMR and CTCA with CT-FFR","multi-parametric CMR assessment and CT coronary angiography with FFR assessment",[14,19],{"name":15,"role":16,"phone":17,"phoneExt":7,"email":18},"Jayanth Arnold","CONTACT","0300 303 1573","jra14@le.ac.uk",{"name":20,"role":16,"phone":7,"phoneExt":7,"email":21},"Mo Elshibly","mmme1@le.ac.uk",[23],{"facility":24,"status":25,"city":26,"state":27,"zip":28,"country":29,"countryCode":30,"cosmosGeoPoint":31,"geoPoint":36,"contacts":37},"Glenfield Hospital","RECRUITING","Leicester","Leics","LE3 (QP","United Kingdom","UK",{"type":32,"coordinates":33},"Point",[34,35],-1.13169,52.6386,{"lat":35,"lon":34},[38,39],{"name":15,"role":16,"phone":17,"phoneExt":7,"email":18},{"name":20,"role":16,"phone":17,"phoneExt":7,"email":21},{"type":41,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR",[43,46,49,51],{"name":44,"class":45},"HeartFlow, Inc.","INDUSTRY",{"name":47,"class":48},"National Heart, Lung, and Blood Institute (NHLBI)","NIH",{"name":50,"class":6},"University of Oxford",{"name":52,"class":6},"University of Glasgow","100420993","cmr-versus-ct-in-coronary-artery-disease-100420993",false,"NCT04761991","CMR Versus CT in Coronary Artery Disease","Comparison of Cardiovascular Magnetic Resonance and Computed Tomography With Fractional Flow Reserve in the Diagnosis of Suspected Coronary Artery Disease","CONCORD","Inclusion Criteria:\n\n* Patients aged ≥18 years\n* Referred for invasive coronary angiography for investigation of chest pain\n\nExclusion Criteria:\n\n* Recent acute coronary syndrome (\\\u003C 6 months)\n* Previous coronary artery bypass grafting\n* Severe claustrophobia\n* Absolute contraindications to CMR - those with MR conditional or safe devices will be included\n* Second-\u002Fthird-degree atrioventricular block\n* Severe chronic obstructive pulmonary disease\n* Moderate-severe asthma\n* Estimated glomerular filtration rate \\\u003C30 ml\u002Fmin\u002F1.73m2\n* Women who are pregnant, breast-feeding or of child-bearing potential( premenopausal women)\n* Contraindication to iodinated contrast\n* Participation in a research study involving an investigational product in the past 12 weeks","ALL","18 Years",{"count":64,"type":65},300,"ESTIMATED","OBSERVATIONAL","CONCORD is a prospective observational study evaluating the diagnostic accuracy of cardiovascular magnetic resonance (CMR) and computed tomography with fractional flow reserve (CT-FFR) in patients with suspected coronary artery disease, using invasive fractional flow reserve (FFR) as the reference standard.",[69],"Coronary Artery Disease",[71,72,73],"MRI","CT-FFR","coronary artery disease","2025-06-26",{"date":76,"type":77},"2025-07-01","ACTUAL",{"date":79,"type":77},"2020-11-05",{"date":81,"type":65},"2025-11-30",{"name":5,"class":6},1]